Latest Insider Transactions at Alignment Healthcare, Inc. (ALHC)
This section provides a real-time view of insider transactions for Alignment Healthcare, Inc. (ALHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alignment Healthcare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alignment Healthcare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2025
|
Sebastian Burzacchi COO - Mgmt Services Org |
SELL
Open market or private sale
|
Direct |
6,694
-1.31%
|
$107,104
$16.53 P/Share
|
|
Mar 19
2025
|
Andreas P. Wagner Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
7,632
-1.66%
|
$122,112
$16.53 P/Share
|
|
Mar 19
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
16,535
-0.35%
|
$264,560
$16.53 P/Share
|
|
Mar 19
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,266
-0.76%
|
$132,256
$16.53 P/Share
|
|
Mar 19
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
11,016
-1.23%
|
$176,256
$16.53 P/Share
|
|
Mar 19
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
6,602
-0.48%
|
$105,632
$16.53 P/Share
|
|
Mar 19
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
7,234
-0.51%
|
$115,744
$16.53 P/Share
|
|
Mar 19
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,101
-0.34%
|
$545,616
$16.53 P/Share
|
|
Mar 19
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,432
-0.39%
|
$182,912
$16.53 P/Share
|
|
Mar 18
2025
|
Andreas P. Wagner Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,888
-2.07%
|
$78,208
$16.89 P/Share
|
|
Mar 18
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
27,114
-1.12%
|
$433,824
$16.89 P/Share
|
|
Mar 18
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
6,725
-1.47%
|
$107,600
$16.89 P/Share
|
|
Mar 18
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
25,000
-3.48%
|
$425,000
$17.01 P/Share
|
|
Mar 18
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
3,923
-0.55%
|
$62,768
$16.89 P/Share
|
|
Mar 18
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
27,535
-0.55%
|
$440,560
$16.89 P/Share
|
|
Mar 18
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,815
-0.92%
|
$221,040
$16.89 P/Share
|
|
Mar 17
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
30,000
-1.23%
|
$450,000
$15.99 P/Share
|
|
Mar 13
2025
|
General Atlantic LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
37,420
+0.06%
|
-
|
|
Mar 13
2025
|
General Atlantic (Aln Hlth), L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
37,420
+0.06%
|
-
|
|
Mar 13
2025
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+3.32%
|
-
|
|
Mar 13
2025
|
Nicholas Robbert Vorhoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,710
+10.81%
|
-
|
|
Mar 13
2025
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,710
+10.81%
|
-
|
|
Mar 13
2025
|
Jody L Bilney Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,484
+12.03%
|
-
|
|
Mar 13
2025
|
Joseph S Konowiecki Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+1.06%
|
-
|
|
Mar 13
2025
|
Jacqueline B Kosecoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+4.04%
|
-
|
|
Mar 13
2025
|
Margaret M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+8.69%
|
-
|
|
Mar 13
2025
|
Yon Jorden Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,258
+11.68%
|
-
|
|
Mar 13
2025
|
Hakan Kardes Chief Experience Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,677
+5.24%
|
-
|
|
Mar 13
2025
|
Robert L. Scavo Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,868
+6.38%
|
-
|
|
Mar 13
2025
|
Robert Thomas Freeman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
93,548
+5.88%
|
-
|
|
Mar 13
2025
|
Hyong Kim Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,065
+9.64%
|
-
|
|
Mar 13
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,789
+13.39%
|
-
|
|
Mar 13
2025
|
Sebastian Burzacchi COO - Mgmt Services Org |
BUY
Grant, award, or other acquisition
|
Direct |
39,677
+13.37%
|
-
|
|
Mar 13
2025
|
Dawn Christine Maroney President |
BUY
Grant, award, or other acquisition
|
Direct |
170,968
+6.53%
|
-
|
|
Mar 13
2025
|
John E Kao Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
338,710
+6.32%
|
-
|
|
Mar 13
2025
|
Andreas P. Wagner Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,109
+12.95%
|
-
|
|
Mar 12
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
5,313
-0.39%
|
$79,695
$15.58 P/Share
|
|
Mar 12
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
53,122
-0.56%
|
$796,830
$15.58 P/Share
|
|
Mar 12
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,692
-0.52%
|
$220,380
$15.58 P/Share
|
|
Mar 12
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
27,243
-0.59%
|
$408,645
$15.58 P/Share
|
|
Mar 12
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
4,856
-0.36%
|
$72,840
$15.58 P/Share
|
|
Mar 11
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
90,000
-2.06%
|
$1,350,000
$15.54 P/Share
|
|
Mar 07
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
21,574
-2.13%
|
$323,610
$15.35 P/Share
|
|
Mar 06
2025
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
55,403
-7.6%
|
$831,045
$15.53 P/Share
|
|
Mar 06
2025
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,626
-1.48%
|
$114,390
$15.53 P/Share
|
|
Mar 06
2025
|
Dawn Christine Maroney President |
SELL
Open market or private sale
|
Direct |
278,917
-10.8%
|
$4,183,755
$15.53 P/Share
|
|
Mar 06
2025
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
10,871
-2.73%
|
$163,065
$15.53 P/Share
|
|
Mar 06
2025
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
554,713
-10.49%
|
$8,320,695
$15.53 P/Share
|
|
Mar 06
2025
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
218,295
-13.34%
|
$3,274,425
$15.53 P/Share
|
|
Mar 06
2025
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
86,659
-11.26%
|
$1,299,885
$15.53 P/Share
|